In this study, we investigated how miR-10b-3p regulated the proliferation, migration, invasion in hepatocellular carcinoma (HCC) at both in vitro and in vivo levels.
| INTRODUCTION
As one of the most prevalent malignancies worldwide, hepatocellular carcinoma (HCC) is also the leading cause of cancer-associated mortality. 1 The intractable disease evolves more sophisticated due to the dysregulation of different genes by promoting the development and progression of HCC. 2 Although improvements have been made in surgery and other treatment methods, it remains at a low level in terms of the 5-year overall survival rate of patients with HCC. The lack of accurate and non-invasive diagnostic tools makes early diagnosis and remission of HCC difficult, resulting in poor prognosis. 3 Hence, it is critical to define the mechanisms of hepatocarcinogenesis at molecular level and to develop novel strategies for HCC early diagnosis and prognosis prediction.
MicroRNAs (miRNAs) play an important role in malignancy by
targeting various tumour suppressors and oncogenes. They also take part in cancer stem cell biology, angiogenesis and epithelialmesenchymal transition, which could also influence carcinogenesis. 4 carcinoma, pancreatic cancer, malignant glioma and HCC. [5] [6] [7] [8] Furthermore, overexpression of miR-10b-3p was observed in tumorous tissue specimens of HCC compared with non-tumour adjacent tissues. 9 The patients with higher miR-10b levels showed shorter survival time. 10 These findings suggest the possible oncogenic role of miR10b-3p in HCC. However, the molecular mechanism remains largely unknown. Given the overexpression of miR-10b-3p in cancer tissues, further investigation into the role and molecular mechanisms of miR10b-3p in cancer development and progression was needed.
CMTM5, also called CKLF-like MARVEL transmembrane domain containing member 5, is a member of CMTM family that could inhibit tumour growth. 11 Being broadly expressed in human tissues, CMTM5
is usually down-regulated in carcinoma tissues. 12, 13 Restoration of CMTM5 may contribute to better morphological transformation, but the antitumour mechanism remains unclear. 14 It was proposed that the understanding of the antitumour mechanism of CMTM5 was critical before it became a new target in the gene therapies for tumours.
Previously, few studies have been performed to investigate the correlation between miRNAs and CMTMs. Our findings indicated that miR-10b-3p directly targeted CMTM5 and negatively regulated its expression, which therefore inhibited the proliferation, migration and invasion of HCC cells. These results provided new insights into the mechanisms by which miR-10b-3p modulated the development of HCC by interacting with CMTM5.
| MATERIALS AND METHODS

| Cell lines and tissue specimens
Human HCC cell lines HepG2, HCCLM7, Huh-7 and HLE as well as human normal hepatic cell lines HL-7702 and THLE3 were purchased from BeNa Culture Collection (Beijing, China) and maintained in Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma, St.
Louis, MO, USA) with 90% DMEM+10%FBS (Invitrogen, Gaithersburg, MD, USA) in an atmosphere with 95% air, 5% CO 2 at 37°C.
Tissue specimens of HCC and adjacent non-tumour tissues (n = 30)
were obtained from China-Japan Union Hospital of Jilin University.
Written informed consent was accessed from all patients (n = 350).
This study was also approved by the ethics committee of ChinaJapan Union Hospital of Jilin University.
| Cell transfection
Cell transfection was conducted using Lipofectamine 3000 reagent.
HepG2 cells were cultured under normal conditions and were inoculated uniformly to 96-well plates at appropriate concentrations (approximately 3 9 10 5 cells/mL in this case). After adherent cell culture, cell transfection was conducted to miR-10b-3p mimics, inhibitors and CMTM5 overexpression plasmids. The cells of the normal group were treated with Lipofectamine only. The mimics and inhibitor etc. were diluted in MEM medium without serum, and then the Lipofectamine 3000 reagent was added to the medium. After incubation for 5 minutes, the diluted Lipofectamine 3000 was mixed with the mixture of last step, which was added to the culture plate of HepG2 cells and incubated at 37°C for 5 hours. Thereafter, the mixture was incubated in MEM medium with 10% FBS for another 48 hours.
| Microarray analysis
The microarray data obtained from TCGA Database (https://cance rgenome.nih.gov/) was used to screen out the differentially expressed genes in HCC. The data included 18 samples (9 tumour tissues and 9 adjacent non-tumorous tissues). Affy and limma packages (R packages) were used to read the expression measures and screen out differently expressed genes that were with fold change value greater than 2 or smaller than -2 (P < .05). 
| QRT-PCR
| Luciferase reporter assay
A bunch of HepG2 cells were seeded onto 24-well plates to grow in 5% CO 2 at 37°C till 70% confluence. Then cells were cotransfected with miR-10b-3p mimics or control mimics with wild-type or mutated-type 3 0 UTR of CMTM5 using Lipofectamine 3000 transfection reagent (Life Technologies, Gaithersburg, MD, USA). Thirty-six hours after transfection, cells were washed with PBS. Luciferase activity was then determined using the Dual-Luciferase Reporter
Assay System (Promega) and a microplate fluorescence reader (BioTek, Winooski, Vermont, USA).
| MTT experiments
Forty-eight hours after transfection, 100 lL of the MTT solution was added to each well of the culture plate. Thereafter, the plate was maintained in an incubator with 37°C and 5% CO 2 . A total of 100 lL of 20% sodium dodecyl sulphate (SDS) was added to each well. The plates were incubated at 37°C for 24 hours. Lastly, a microplate reader was used to read the OD values at 490 nm. Each group contained 3 replicates, and each experiment was repeated in triplicate.
| Colony formation assay
Transfected cells were lysed and then seeded onto 6-well plates.
When colonies were visible after approximately 2 weeks, they were washed with PBS and fixed with 4% paraformaldehyde for 20 minutes before they were stained with GIMSA for 30 minutes. Finally, cells were air-dried. Colonies were counted under an Olympus CK2 phase-contrast inverted microscope (Olympus, Tokyo, Japan). We randomly chose 5 fields for observation and repeated the experiment for three times.
| Wound-healing assay
In brief, 1 9 10 5 transfected cells were plated in 6-well plates till 90% confluence in DMEM containing FBS. Then, a scratch was created on the surface of every cell layer using 200-lL pipette tips. Detached cells were washed away with PBS. After the scratch, new medium was used for further culture for another 24 hours. Finally, woundhealing areas were measured and recorded under a microscope.
| Cell invasion assay
Cells were initially starved for 24 hours before the suspension. Then they were lysed and washed with PBS before being resuspended with serum-free media. 1 9 10 5 cells were plated in the upper well, and 600 lL of DMEM medium containing 10% FBS was served as the chemoattractant in the lower chambers. After 24 hours, invading cells were fixed with 4% paraformaldehyde, stained with 0.1% crystal violet, air-dried and photographed using a light microscope. The number was also counted under the microscope as well.
| In vivo experiments
We purchased 16 healthy and specific pathogen-free BALB/C mice (5-week-old, female, average body weight of 25 g, purchased from
Cavens Lab Animal Co., Ltd.). All the mice were given proper water and food. They were housed in 12-hour light/dark cycles until exper- 
| Survival analysis
The survival outcomes of 320 patients were analysed. High level was defined as a fold change value bigger than 2, whereas a low level was defined as a fold change value smaller than -2. A total of 320 patients were included in the following study (details of the survival analysis have been given in the main text), and among them, 228 were with high miR-10b-3p levels, and 92 were with low miR10b-3p levels; and 218 were with low CMTM5 levels, and 102 were with high CMTM5 levels.
| Statistical analysis
The statistical analysis and graphical depiction were performed with GraphPad Prism 6.0 software (San Diego, CA, USA) and the SPSS 16.0 software (SPSS, Chicago, IL, USA). All data from at least three independent experiments were expressed as mean AE SD (standard deviation). Statistical differences were determined by ANOVA or Student's t test. A value of P < .05 was considered statistically significant.
3 | RESULTS
| CMTM5 was down-regulated in HCC tissues
Microarray results demonstrated that 5 genes were up-regulated, whereas 14 genes were down-regulated in HCC tissues ( Figure 1A ), and we chose CMTM5 for further study. Expression levels of CMTM5
and miR-10b-3p in HCC tissues (n = 30) and adjacent normal tissues The modulation of CMTM5 expression did not affect the expression of miR-10b-3p ( Figure 2E ). On the other hand, the expression of CMTM5 was higher in CMTM5 group and inhibitor group, whereas lower in mimics group. The cotransfection of CMTM5 and mimics did not affect the expression of CMTM5 ( Figure 2F ). Western blot results showed that miR-10b-3p could suppress CMTM5
( Figure 2G , P < .01). Therefore, we concluded that miR-10b-3p was able to suppress CMTM5 in HCC cell line HepG2.
| miR-10b-3p promoted HepG2 cell proliferation, migration and invasion by suppressing CMTM5
Enforced expression of CMTM5 dramatically reduced cell proliferation (in both MTT assay and colony formation assay) in HepG2 cells, whereas enforced expression of miR-10b-3p significantly promoted cell proliferation. The cotransfection of mimics and CMTM5 overexpression plasmids led to no significant change in cell proliferation.
( Figure 3A -C, P < .01). Transwell assay results displayed fewer invaded cells in CMTM5 overexpression group but more in miR-10b-3p group ( Figure 3D ,E, P < .01). Besides, the wound-healing area for F I G U R E 1 CMTM5 was low-expressed, and miR-10b-3p was high-expressed in HCC tissues. A, Heat map showed 5 high-expressed and 14 low-expressed genes in tumour tissues (n = 9) and normal tissues (n = 9), with CMTM5 down-regulated in HCC tissues. B-C, QRT-PCR confirmed that CMTM5 was low-expressed and miR-10b-3p was high-expressed in tumour tissues (n = 30). ****P < .0001, compared with tumour tissues. D-E, QRT-PCR confirmed that CMTM5 was low-expressed and miR-10b-3p was high-expressed in HCC cell lines. GAPDH and U6 were used as internal controls for gene and miRNA, respectively. *P < .05, **P < .01, compared with HL-7702 cell line CMTM5 overexpressed cells was smaller, but miR-10b-3p-transfected cells showed bigger wound-healing area ( Figure 3F ,G, P < .05).
These results suggested that CMTM5 could impair the proliferation, migration and invasion of HepG2 cells.
| MiR-10b-3p and CMTM5 predicted overall survival in patients with HCC
A total of 320 patients were included in the follow-up study. The overall survival rates of the patients were shown in Figure 4 .
Patients with low expression of miR-10b-3p were accompanied with better overall survival ( Figure 4A , P = .0006), whereas patients with low expression of CMTM5 were accompanied with worse overall survival ( Figure 4B , P = .0015). The results revealed that miR-10b-3p
had correlation with poor prognosis, whereas CMTM5 was connected with good prognosis for patients with HCC. F I G U R E 2 CMTM5 was a direct target of miR-10b-3p in HCC cells. A, The binding sequences of miR-10b-3p and CMTM5 (at position 239-245) were illustrated. B, Dual-luciferase reporter gene assay was conducted to verify that miR10b-3p significantly masked the wild-type 3 0 UTR but not the mutated-type 3 0 UTR of CMTM5. **P < .01, compared with the mimics control group. C, The transfection efficiency of miR-10b-3p mimics and inhibitor in HepG2 cells was confirmed. D, The transfection efficiency of CMTM5 overexpression plasmids in HepG2 cells was confirmed. E, qRT-PCR results revealed that mimics group and CMTM5 + miR group showed significantly up-regulated miR-10b-3p in HepG2 cells. U6 was used as the internal control. F, qRT-PCR results revealed that cells of CMTM5 group showed significantly upregulated CMTM5 expression, whereas those of mimics group showed downregulated CMTM5 expression in HepG2 cells. GAPDH was used as the internal control. G, Western blot analysis results confirmed that CMTM5 was downregulated by miR-10b-3p mimics in HepG2 cells. *P < .05, **P < .01, compared with the control group. Mimics: miR-10b-3p mimics; CMTM5: CMTM5 overexpression; CMTM5 + miR: CMTM5 overexpression plus miR-10b-3p mimics two. An earlier study revealed that miR-10b might target RhoC, uPAR, MMP-2 and MMP-9. 15 Other researches implied CSMD1 and CADM1 could also be regulated by miR-10b. 5, 18 Most of these genes acted as tumour suppressors, so we assumed that miR-10b could suppress certain anticancer factors including CMTM5. In our study, we proved that CMTM5 was a target gene of miR-10b-3p in HepG2 cell line.
The ectopic gene expression could influence cell activities. After we modified the expression of miR-10b-3p and CMTM5, we found the altered cell proliferation, invasion and migration in single-transfected group, whereas no obvious alteration on cell activities was found.
As we have found that the modification of miR-10b-3p and CMTM5 expressions changed cell activities, we then supposed that they may also be associated with prognosis. Some studies demonstrated that miR-10b-3p level was significantly higher in HCC patients with worse overall survival outcome, indicating higher miR10b-3p expression level was an independent predictor of poor prognosis, 10, 18, 19 supporting our results that the overexpression of miR-10b-3p had poor prognosis in patients with HCC. However, CMTM5 expression had no significant impact on the prognosis of patients with ovarian cancer by Kaplan-Meier method, 13 whereas our study showed that patients with high expression of CMTM5 had better prognosis outcome. The difference may be caused by the types of cancer and the different sample sizes (46 in their study and 320 in ours).
Limitations still exist in this study. Future studies are required to further clarify whether other factors participated in miR-10b-3p/ CMTM5 signalling axis and affected HCC progression. In addition, miR-10b and CMTM5 were found correlated with HCC metastasis.
Overexpression of CMTM5 and CMTM3, which are two members of CMTM family, inhibited tumour progression both in vitro and In vivo. 11, 20 The two studies indicated that miR-10b and CMTM5 could also be useful biomarkers for HCC metastasis, which can be further investigated in the following studies.
In conclusion, our study indicated that up-regulation of miR-10b-3p could promote the progression of HCC cells by suppressing CMTM5 expression. Our findings may cast new light on the novel therapy targets of HCC.
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